Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 141

1.

N-terminal pro-brain natriuretic peptide (NT-proBNP) predicts the cardio-renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk.

Idzerda NMA, Persson F, Pena MJ, Brenner BM, Brunel P, Chaturvedi N, McMurray JJ, Parving HH, de Zeeuw D, Heerspink HJL.

Diabetes Obes Metab. 2018 Jul 10. doi: 10.1111/dom.13465. [Epub ahead of print]

PMID:
29987919
2.

Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial.

Lipiecki J, Brunel P, Morice MC, Roguelov C, Walsh SJ, Richardt G, Eerdmans P, Zambahari R, Berland J, Copt S, Stoll HP, Urban P.

EuroIntervention. 2018 Jul 20;14(4):e418-e425. doi: 10.4244/EIJ-D-18-00293.

3.

Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score.

Auffret V, Cottin Y, Leurent G, Gilard M, Beer JC, Zabalawi A, Chagué F, Filippi E, Brunet D, Hacot JP, Brunel P, Mejri M, Lorgis L, Rouault G, Druelles P, Cornily JC, Didier R, Bot E, Boulanger B, Coudert I, Loirat A, Bedossa M, Boulmier D, Maza M, Le Guellec M, Puri R, Zeller M, Le Breton H; ORBI and RICO Working Groups.

Eur Heart J. 2018 Jun 7;39(22):2090-2102. doi: 10.1093/eurheartj/ehy127.

PMID:
29554243
4.

Efficacy and effectiveness of valsartan/amlodipine and valsartan/amlodipine/hydrochlorothiazide in hypertension: randomized controlled versus observational studies.

Sison J, Vega RMR, Dayi H, Bader G, Brunel P.

Curr Med Res Opin. 2018 Mar;34(3):501-515. doi: 10.1080/03007995.2017.1412682. Epub 2018 Jan 22.

PMID:
29210288
5.

Falls and Delirium: Platypnea-Orthodeoxia Syndrome.

Putot A, Laborde C, Fichot M, Brunel P, Deidda M, Guepet H, Manckoundia P.

Am J Med. 2018 Mar;131(3):250-252. doi: 10.1016/j.amjmed.2017.11.003. Epub 2017 Nov 20. No abstract available.

PMID:
29157648
6.

Triple-combination therapy in the treatment of hypertension: a review of the evidence.

Düsing R, Waeber B, Destro M, Santos Maia C, Brunel P.

J Hum Hypertens. 2017 Aug;31(8):501-510. doi: 10.1038/jhh.2017.5. Epub 2017 Feb 23. Review.

PMID:
28230062
7.

Performance of Laser Megajoule's x-ray streak camera.

Zuber C, Bazzoli S, Brunel P, Burillo M, Fronty JP, Gontier D, Goulmy C, Moreau I, Oudot G, Rubbelynck C, Soullié G, Stemmler P, Trosseille C.

Rev Sci Instrum. 2016 Nov;87(11):11E303.

PMID:
27910354
8.

Picosecond X-ray streak camera dynamic range measurement.

Zuber C, Bazzoli S, Brunel P, Fronty JP, Gontier D, Goulmy C, Raimbourg J, Rubbelynck C, Trosseille C.

Rev Sci Instrum. 2016 Sep;87(9):093501.

PMID:
27782554
9.

The EBC TWO Study (European Bifurcation Coronary TWO): A Randomized Comparison of Provisional T-Stenting Versus a Systematic 2 Stent Culotte Strategy in Large Caliber True Bifurcations.

Hildick-Smith D, Behan MW, Lassen JF, Chieffo A, Lefèvre T, Stankovic G, Burzotta F, Pan M, Ferenc M, Bennett L, Hovasse T, Spence MJ, Oldroyd K, Brunel P, Carrie D, Baumbach A, Maeng M, Skipper N, Louvard Y.

Circ Cardiovasc Interv. 2016 Sep;9(9). pii: e003643. doi: 10.1161/CIRCINTERVENTIONS.115.003643.

PMID:
27578839
10.

First set of gated x-ray imaging diagnostics for the Laser Megajoule facility.

Rosch R, Trosseille C, Caillaud T, Allouche V, Bourgade JL, Briat M, Brunel P, Burillo M, Casner A, Depierreux S, Gontier D, Jadaud JP, Le Breton JP, Llavador P, Loupias B, Miquel JL, Oudot G, Perez S, Raimbourg J, Rousseau A, Rousseaux C, Rubbelynck C, Stemmler P, Troussel P, Ulmer JL, Wrobel R, Beauvais P, Pallet M, Prevot V.

Rev Sci Instrum. 2016 Mar;87(3):033706. doi: 10.1063/1.4942930.

PMID:
27036783
11.

A case study of proton shuttling in palladium catalysis.

Monot J, Brunel P, Kefalidis CE, Espinosa-Jalapa NÁ, Maron L, Martin-Vaca B, Bourissou D.

Chem Sci. 2016 Mar 1;7(3):2179-2187. doi: 10.1039/c5sc04232a. Epub 2015 Dec 7.

12.

Renal outcomes with aliskiren in patients with type 2 diabetes: a prespecified secondary analysis of the ALTITUDE randomised controlled trial.

Heerspink HJ, Persson F, Brenner BM, Chaturvedi N, Brunel P, McMurray JJ, Desai AS, Solomon SD, Pfeffer MA, Parving HH, de Zeeuw D.

Lancet Diabetes Endocrinol. 2016 Apr;4(4):309-17. doi: 10.1016/S2213-8587(15)00469-6. Epub 2016 Jan 14.

PMID:
26774608
13.

Cardiac rehabilitation and 5-year mortality after acute coronary syndromes: The 2005 French FAST-MI study.

Pouche M, Ruidavets JB, Ferrières J, Iliou MC, Douard H, Lorgis L, Carrié D, Brunel P, Simon T, Bataille V, Danchin N.

Arch Cardiovasc Dis. 2016 Mar;109(3):178-87. doi: 10.1016/j.acvd.2015.09.009. Epub 2015 Dec 23.

14.

Effects of aliskiren in diabetic and non-diabetic patients with coronary artery disease: Insights from AQUARIUS.

Puri R, Nissen SE, Menon V, Shao M, Hsu A, Bakris GL, Kastelein JJ, Williams B, Armbrecht J, Brunel P, Kataoka Y, Nicholls SJ.

Atherosclerosis. 2015 Dec;243(2):553-9. doi: 10.1016/j.atherosclerosis.2015.10.019. Epub 2015 Oct 20.

PMID:
26523993
15.

Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial.

Heerspink HJ, Ninomiya T, Persson F, Brenner BM, Brunel P, Chaturvedi N, Desai AS, Haffner SM, Mcmurray JJ, Solomon SD, Pfeffer MA, Parving HH, de Zeeuw D.

Diabetes Obes Metab. 2016 Feb;18(2):169-77. doi: 10.1111/dom.12600. Epub 2016 Jan 13.

PMID:
26511599
16.

Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk.

Urban P, Meredith IT, Abizaid A, Pocock SJ, Carrié D, Naber C, Lipiecki J, Richardt G, Iñiguez A, Brunel P, Valdes-Chavarri M, Garot P, Talwar S, Berland J, Abdellaoui M, Eberli F, Oldroyd K, Zambahari R, Gregson J, Greene S, Stoll HP, Morice MC; LEADERS FREE Investigators.

N Engl J Med. 2015 Nov 19;373(21):2038-47. doi: 10.1056/NEJMoa1503943. Epub 2015 Oct 14.

17.

Mortality following a cardiovascular or renal event in patients with type 2 diabetes in the ALTITUDE trial.

Jhund PS, McMurray JJ, Chaturvedi N, Brunel P, Desai AS, Finn PV, Haffner SM, Solomon SD, Weinrauch LA, Claggett BL, Pfeffer MA.

Eur Heart J. 2015 Sep 21;36(36):2463-9. doi: 10.1093/eurheartj/ehv295. Epub 2015 Jul 18.

PMID:
26188211
18.

N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.

Goussot S, Mousson C, Guenancia C, Stamboul K, Brunel P, Brunet D, Touzery C, Cottin Y, Zeller M.

Am J Cardiol. 2015 Sep 15;116(6):865-71. doi: 10.1016/j.amjcard.2015.06.007. Epub 2015 Jun 25.

PMID:
26183794
19.

The Log book for the secondary prevention of coronary artery disease: A pilot study.

Vaillant A, Dentan G, Laurent Y, Aurélie G, Beer JC, Germin F, Boch É, Casillas JM, Brunel P, Touzery C, Cottin Y, Zeller M, Morel G; pour le réseau de prise en charge et de prévention des infarctus du myocarde de Côte-d’Or (RPC-PIM).

Presse Med. 2015 Sep;44(9):e301-9. doi: 10.1016/j.lpm.2014.11.020. Epub 2015 Jul 2.

PMID:
26144276
20.

Effects of treatment withdrawal on brachial and central aortic pressure after direct renin inhibition or angiotensin receptor blockade.

Lacy PS, Brunel P, Bader G, Jones A, Baschiera F, Düsing R, Williams B.

J Renin Angiotensin Aldosterone Syst. 2015 Sep;16(3):614-22. doi: 10.1177/1470320315579592. Epub 2015 May 5.

PMID:
25944854

Supplemental Content

Loading ...
Support Center